The trading price of Adaptive Biotechnologies Corp (NASDAQ:ADPT) closed lower on Friday, February 07, and closing at $7.84, -2.12% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $7.66 and $8.19. In examining the 52-week price action we see that the stock hit a 52-week high of $8.33 and a 52-week low of $2.28. Over the past month, the stock has gained 10.42% in value.
Adaptive Biotechnologies Corp, whose market valuation is $1.16 billion at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest ADPT has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned ADPT a recommendation rating is 11. Out of them, 6 rate it a Hold, while 4 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Adaptive Biotechnologies Corp (ADPT) as Underweight, while 1 advise Sell. Analysts have rated the stock Hold, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that ADPT’s price is currently 5.00% off the SMA20 and 15.63% off the SMA50. The RSI metric on the 14-day chart is currently showing 57.63, and weekly volatility stands at 8.06%. When measured over the past 30 days, the indicator reaches 8.24%. Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s beta value is currently sitting at 1.55, while the Average True Range indicator is currently displaying 0.58. With analysts defining $5-$18 as the low and high price targets, we arrive at a consensus price target of $14 for the trailing 12-month period. The current price is about 36.22% off the estimated low and -129.59% off the forecast high, based on this estimate. Investors will be thrilled if ADPT’s share price rises to $14, which is the median consensus price. At that level, ADPT’s share price would be -78.57% below current price.
To see how Adaptive Biotechnologies Corp stock has been performing in comparison to its peers in the industry, here are the numbers: ADPT stock’s performance was -2.12% in the latest trading, and 107.96% in the past year.
An evaluation of the daily trading volume of Adaptive Biotechnologies Corp (NASDAQ:ADPT) indicates that the 3-month average is 1.39 million. However, this figure has increased over the past 10 days to an average of 1.13.
Currently, records show that 147.56 million of the company’s shares remain outstanding. The insiders hold 3.28% of outstanding shares, whereas institutions hold 93.06%. The stats also highlight that short interest as of 2025-01-15, stood at 8.66 million shares, resulting in a short ratio of 6.51 at that time. From this, we can conclude that short interest is 753.00 of the company’s total outstanding shares. It is noteworthy that short shares in January were down slightly from the previous month’s figure, which was 9.03 million. However, since the stock’s price has seen 30.78% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
